Trial intelligence / Profile preview

CAROTID ARMYDA trial

2011-005330-18Phase 3Active

Sponsor
Università Campus Bio-Medico di Roma
Start
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of clopidogrel and atorvastatin in carotid atheroma (CAS) and brain ischemia (3 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: New ipsilateral cerebral ischemic events within 24 hours. Started Dec 2011; status: active.

02

Drugs

clopidogrelatorvastatin
03

Conditions

carotid atheroma (CAS)brain ischemia

Beyond the preview

Go deeper on 2011-005330-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005330-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call